Detalhe da pesquisa
1.
[Peripheral Neuropathy and Muscle Disorders as Immune-Related Adverse Events].
Brain Nerve;
76(5): 605-611, 2024 May.
Artigo
em Japonês
| MEDLINE | ID: mdl-38741503
2.
B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis.
Front Immunol;
15: 1382320, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711503
3.
Taste disorders and alopecia in myasthenia gravis.
BMC Neurol;
24(1): 139, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664714
4.
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.
Ann Clin Transl Neurol;
11(5): 1338-1346, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572524
5.
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan.
Neurol Clin Pract;
14(3): e200276, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38544885
6.
Pathologic Features of Anti-Ku Myositis.
Neurology;
102(8): e209268, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547417
7.
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study.
Muscle Nerve;
69(5): 556-565, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38380691
8.
Clinicopathological predictors of postoperative long-term myasthenic status in resected thymoma with myasthenia gravis.
Surg Today;
2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416144
9.
[Clinical Features of Myasthenia Gravis as an Immune-related Adverse Event].
Brain Nerve;
76(1): 27-32, 2024 Jan.
Artigo
em Japonês
| MEDLINE | ID: mdl-38191136
10.
Serious Bacterial Infections Associated with Eculizumab: A Pharmacovigilance Study.
Intern Med;
63(8): 1061-1066, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37690847
11.
Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan.
J Neuroimmunol;
385: 578241, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952282
12.
Association Between HLA Alleles and Autoantibodies in Dermatomyositis Defined by Sarcoplasmic Expression of Myxovirus Resistance Protein A.
J Rheumatol;
50(9): 1159-1164, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321638
13.
Overlap syndrome with antibodies against multiple transfer-RNA components presenting antisynthetase syndrome.
Neuromuscul Disord;
33(5): 405-409, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37037049
14.
Muscle pathology of antisynthetase syndrome according to antibody subtypes.
Brain Pathol;
33(4): e13155, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882048
15.
Dysautonomia associated with immune checkpoint inhibitors.
J Neurol;
270(7): 3413-3423, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939931
16.
Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis.
Neurotherapeutics;
20(2): 518-523, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36607596
17.
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis.
J Neurol Neurosurg Psychiatry;
94(6): 467-473, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693723
18.
Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis.
Exp Neurol;
361: 114300, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525997
19.
Association of immune-mediated necrotizing myopathy with HLA polymorphisms.
HLA;
101(5): 449-457, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565042
20.
Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor.
Eur J Cancer;
180: 1-3, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36527972